Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001415889-25-015778)

Filing Details

Accession Number:: 0001415889-25-015778
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-06-05 16:38:56
Reporting Period:: 2025-06-03

Filing Date:: 2025-06-05
Accepted Time:: 2025-06-05 16:38:56
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1730430	Kiniksa Pharmaceuticals International Plc	KNSA	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1835458	Mark Ragosa	23 Old Bond Street, Third Floor London X0 W1S 4PZ	Chief Financial Officer	No	No	No	No

Transaction Summary

Sold:	18,299 shares	Avg. Price: $28.80	Total Value: $527,011.20
Number of Shares After Transactions:	27,009 shares

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Ordinary Share	Acquisiton	2025-06-03	18,299	$18.00	45,308	No	4	M	Direct
Class A Ordinary Share	Disposition	2025-06-03	18,299	$28.80	27,009	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Ordinary Share	Share Option	Disposition	2025-06-03	18,299	$0.00	18,299	$18.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2028-05-22	No	4	M	Direct

Footnotes

This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 3, 2024.
The option is fully vested and exercisable.